Navigation Links
Cancer Survivor & Award-Winning Journalist, Jamie Reno, Announces Genelux Corporation's Advancement in Cancer Research
Date:7/19/2013

San Diego, CA (PRWEB) July 19, 2013

Jamie Reno, an award-winning journalist, cancer survivor and patient advocate, discussed in depth the discoveries by a small biotech firm in San Diego that has been flying under the radar for the past decade. What’s the big discovery? They may have found the cure for cancer.

While Genelux is currently conducting Phase I/II human trials for this virus at Moores, Sloan Kettering, Royal Marsden Hospital in London, and the Tubingen University Hospital in Germany, most people have not heard of this treatment, or this company. The virus-based treatment developed by Genelux, a company founded in 2001 that has offices in California and Europe, could completely change the perspective and approach on cancer care. Genelux, which has received very little publicity, has developed a virus-based treatment called GL-ONC1 that kills cancer cells throughout the body safely and effectively.

While there are plenty of so-called wonderdrugs that kill cancer in mice but do not work in people, the virus-based treatment from Genelux has been proven effective in people. Human trials for GL-ONC1 are already underway at such prestigious cancer institutions as Memorial Sloan-Kettering in New York and the UC San Diego Moores Cancer Center. More than 60 people, mostly patients who have exhausted every other treatment option, have enrolled in these trials for a variety of cancers. And the responses have been amazing.

Reno is not big on hype and hyperbole when it comes to cancer treatments, but the inspirational story of Genelux can serve as a beacon of hope for those who suffer from cancer, and often times, the toxic treatment that follows. Reno believes their work could result in an entirely new paradigm in the field of oncology and delivery of medicine in general.

The virus, which was used in the first smallpox vaccine nearly two centuries ago, is delivered intravenously, and then navigates through the body’s immune response to reach its target. It intelligently locates and kills all cancer cells throughout the body (solid tumors, liquid tumors, cancer stem cells, and metastasis). The treatment is very safe and there are no side effects other than very mild fever for and some chills for a few hours at most.

Using a virus to treat cancer is not a new study; it has been around for several decades. Besides vaccine, other oncolytic viruses used in clinical trials are adenovirus, reovirus, measles, herpes simplex and Newcastle disease viruses. But Genelux has taken it to new heights with this treatment, which could even be a cure.

About: Jamie Reno, an award-winning correspondent for Newsweek for 20 years, has also written for The Daily Beast, The New York Times, Sports Illustrated, Rolling Stone, People, Men’s Journal, ESPN, Los Angeles Times, TV Guide, MSNBC, Newsmax, Entertainment Weekly, and USA Today. Reno has won more than 95 writing awards including the National Magazine Award for General Excellence, the highest award in magazine journalism. Reno is also a three-time, 17-year survivor of stage IV non-Hodgkin's lymphoma. He has written two acclaimed books on cancer survivorship and is always on the lookout for new cancer treatments. He lives in San Diego with his wife, Gabriela, and their daughter, Mandy.

If you're a cancer patient or just want more information on Genelux or other companies that offer new, innovative cancer treatments, contact Jamie Reno directly.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10938602.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New plan of attack in cancer fight
2. Voices Against Brain Cancer Comments on Discovery of Nano Drug That May Aid in Treatment of Brain Tumors
3. AAHD Helps in Your Fight Against Breast Cancer
4. Arena Football League (AFL) Kicker Kyle Brotzman Joins Kicking For The Dream’s Effort to Fight Ovarian Cancer
5. Thwarting protein production slows cancer cells malignant march
6. Cancer prehabilitation can reduce complications and improve treatment outcomes
7. Menopause symptoms worse in cancer survivors
8. Texas Man Suffering from Bladder Cancer Because of Actos Use, Alleges Lawsuit Filed by Parker Waichman LLP
9. Intelligent knife tells surgeon which tissue is cancerous
10. TGen-TD2-Scottsdale Healthcare breast cancer pilot study shows value of proteomic mapping
11. Cosmetics and Beauty Products Could Cause Cancer: New Website Explores Evidence Online
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... , ... May 26, 2016 , ... ... discovery of thousands of defective respirators, according to court documents and SEC filings. ... of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, Los ...
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, Hope For ... their lives in military battle for the country. The nonprofit Hope For Heroes ... more programs that empower independence for disabled military veterans, as well as police, firemen, ...
(Date:5/26/2016)... ... 26, 2016 , ... MadgeTech will be showcasing its line of data ... Hampshire at the MadgeTech headquarters. With products sold in more than 100 countries around ... including NASA. , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech ...
(Date:5/26/2016)... ... May 26, 2016 , ... In an effort to provide hair restoration information to the widest ... and those who do not use the app. Dr. Mohebi, the founder of Parsa Mohebi ... Mohebi Live . , Dr. Mohebi says, “The positive response to the Snapchat videos ...
(Date:5/26/2016)... ... 26, 2016 , ... The Lung Institute has partnered with the ... starting June 6 at their clinic in downtown Tampa. The class is complimentary for ... Institute has created a free downloadable 4 Week Smoking Cessation Guide for ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... -- The healthcare sector is large and ... falling under its umbrella.  A rather overlooked sector are ... about, these healthcare companies are still trying to prove ... by far the largest consumer of the healthcare market ... Nutranomics Inc. (OTC: NNRX), KollagenX Corp. (OTCQB: KGNX), Bioelectronics ...
(Date:5/26/2016)... A key trend that will ... of new treatments. Cardax, a development stage life sciences ... therapy is expected to fulfil large unmet medical needs ... studies to develop new treatments for osteoarthritis. One such ... in osteoarthritis are being investigated, and early trials of ...
(Date:5/26/2016)... , May 26, 2016   Change ... and analytics, network solutions and technology-enabled services ... it entered into a strategic channel partnership ... outpatient software solutions and revenue cycle management ... hospitals and rehabilitation clinics to optimize revenue, ...
Breaking Medicine Technology: